A study performed in a mouse model of AD counted the number of GFAP+ cells in different brain areas, specifically in the CA1, the CA3, the dentate gyrus, the subiculum, the entorhinal cortex, and the striatum. This evidence concerns the gene GFAP and Alzheimer disease.